Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
South Med J ; 113(12): 629-632, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-33263131

RESUMO

Mentorship is vital in the effective progression of a physician's educational training. This journey often begins during a physician's undergraduate career prior to advancing on to medical school, residency, and fellowship training. These levels of training distinguish different tiers of mastery, and collaboration among these tiers is integral in order to facilitate a meaningful transition into an independent physician.


Assuntos
Educação Médica/organização & administração , Educação de Graduação em Medicina/organização & administração , Humanos , Internato e Residência/organização & administração , Mentores , Faculdades de Medicina/organização & administração , South Carolina , Estudantes de Medicina
3.
Am Surg ; 89(8): 3579-3581, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-36897265

RESUMO

Triple-negative breast cancer (TNBC) is typically managed with neoadjuvant chemotherapy (NAC). Metaplastic breast cancer (MBC), a subtype of TNBC, demonstrates different histologic characteristics and less responsiveness to NAC. We performed this study to achieve a better understanding of MBC, including the impact of neoadjuvant chemotherapy. We identified patients diagnosed with MBC from January 2012 to July 1, 2022. A control group of TNBC breast cancer patients from 2020 who did not meet the criteria for MBC was identified. Demographic data, tumor and nodal characteristics, management strategies employed, response to systemic chemotherapy, and treatment outcomes were recorded and compared between groups. A total of 22 patients were included in the MBC group and demonstrated a 20% response to NAC compared to an 85% response rate in the 42 patients in the TNBC group (P = .003). Five patients have recurred (23%) in the MBC group compared to none in the TNBC group (P = .013).


Assuntos
Neoplasias de Mama Triplo Negativas , Humanos , Neoplasias de Mama Triplo Negativas/patologia , Prognóstico , Recidiva Local de Neoplasia/patologia , Resultado do Tratamento , Terapia Neoadjuvante
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA